SOD1 and Nephropathy: Our results confirmed that the amount of serum SOD and GSH was increased and MDA was decreased following the treatment of FST in a dose-dependent manner, which indicated that FST could reduce ROS levels and alleviate oxidative stress-induced kidney damage.